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Summary  Stress  or  elevated  glucocorticoids  during  sensitive  windows  of  fetal  development
increase  the  risk  of  neuropsychiatric  disorders  in  adult  rodents  and  humans,  a  phenomenon
known as  glucocorticoid  programming.  11-Hydroxysteroid  dehydrogenase  type  2  (11-HSD2),
which catalyses  rapid  inactivation  of  glucocorticoids  in  the  placenta,  controls  access  of  maternalAffective  behaviors;
Brain  11-HSD2
glucocorticoids  to  the  fetal  compartment,  placing  it  in  a  key  position  to  modulate  glucocorti-
coid programming  of  behavior.  However,  the  importance  of  the  high  expression  of  11-HSD2
within the  midgestational  fetal  brain  is  unknown.  To  examine  this,  a  brain-speciﬁc  knock-
out of  11-HSD2  (HSD2BKO)  was  generated  and  compared  to  wild-type  littermates.  HSD2BKO
have markedly  diminished  fetal  brain  11-HSD2,  but  intact  fetal  body  and  placental  11-
HSD2 and  normal  fetal  and  placental  growth.  Despite  normal  fetal  plasma  corticosterone,
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. Introduction
ower  birth  weight,  a  marker  of  an  adverse  fetal  envi-
onment,  associates  with  neuropsychiatric  abnormalities  in
ater  life  (Khashan  et  al.,  2011).  Similarly,  maternal  expo-
ure  to  stress  during  pregnancy  associates  with  an  increased
ffspring  prevalence  of  psychiatric  disease  and  cognitive
ysfunction  (Weinstock,  2008).  Both  may  be  underpinned
y  elevated  maternal  glucocorticoids  reaching  the  fetus
t  inappropriate  times  during  development,  retarding  fetal
rowth  and  altering  the  timing  of  cessation  of  cellular  (neu-
onal  and  glial)  proliferation  and  terminal  differentiation
Cottrell  and  Seckl,  2009).  Maternal  glucocorticoid  admin-
stration  causes  behavioral  and  cognitive  abnormalities  in
he  offspring  in  a  range  of  species  (Pryce  et  al.,  2011;
elberg  et  al.,  2000),  including  humans  (Pesonen  et  al.,
009;  Trautman  et  al.,  1995;  Yeh  et  al.,  2004).
To  maintain  the  fetus  in  a  low  glucocorticoid  environment
n  the  face  of  10-fold  higher  maternal  blood  concentra-
ions,  the  placenta  expresses  the  potent  glucocorticoid-
etabolising  enzyme,  11-hydroxysteroid  dehydrogenase
ype  2  (11-HSD2)  which  catalyses  the  rapid  conversion  of
ctive  cortisol  and  corticosterone  to  inert  11-keto  forms
cortisone,  11-dehydrocorticosterone)  (Brown  et  al.,  1996a;
urton  et  al.,  1996).  This  affords  a  relative  enzymic  ‘bar-
ier’  which  effectively  excludes  ∼80%  of  maternal  active
lucocorticoids  from  the  fetal  compartment  (Benediktsson
t  al.,  1997).  Placental  11-HSD2  is  reduced  with  maternal
alnutrition,  stress  or  illness  in  rodent  models  and  humans
Cottrell  et  al.,  2014;  Mairesse  et  al.,  2007;  O’Donnell  et  al.,
012);  it  is  bypassed  by  poor  substrates  such  as  dexametha-
one  and  betamethasone.
Mice  globally  deﬁcient  in  11-HSD2  (11-HSD2−/−)
ave  low  birth-weight  and  exhibit  increased  anxiety  and
epressive-like  adult  behaviors  (Holmes  et  al.,  2006a;
yrwoll  and  Holmes,  2012).  Similarly,  the  offspring  of
regnant  rats  administered  carbenoxolone,  a  soluble  deriva-
ive  of  the  potent  11-HSD  inhibitor  in  liquorice,  show
nxiety-related  behaviors  as  adults  (Welberg  et  al.,  2000).  In
regnant  women,  greater  ingestion  of  liquorice  in  foodstuffs
ssociates  with  reduced  cognition  and  increased  anxiety  and
ttentional  deﬁcits  in  offspring  (Raikkonen  et  al.,  2009,
010).  Such  data  are  consistent  with  the  hypothesis  that
lacental  11-HSD2  protects  the  developing  fetus  from
aternal  glucocorticoids  and  their  effects  to  programme
he  fetal  brain.  Furthermore,  11-HSD2−/− mice  also  have
maller,  dysfunctional  placentas  (Wyrwoll  et  al.,  2009) and
ence  glucocorticoid  effects  directly  on  the  placenta  rather
han  just  the  fetus  may  underpin,  in  part,  the  programmed
henotype.  Indeed  both  fetal  growth  restriction  and  pla-
ental  insufﬁciency  are  consistent  ﬁndings  across  models  of
lucocorticoid  programming.
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rain  corticosterone  levels  at  midgestation.  As  adults,  HSD2BKO
d  have  cognitive  impairments.  However,  unlike  complete  feto-
ow  no  anxiety-like  behavioral  deﬁcits.  The  clear  mechanistic
mponents  of  depression  and  cognition  from  anxiety  implies  dis-
,  affording  potential  opportunities  for  stratiﬁed  interventions.
 by  Elsevier  Ltd.  This  is  an  open  access  article  under  the  CC  BY
.org/licenses/by/4.0/).
However,  there  is  also  substantial  fetal  expression  of
1-HSD2,  notably  in  the  human,  rat,  mouse  and  pig  fetal
rain  (Brown  et  al.,  1996a,  1996b).  This  shows  locus-speciﬁc
atterns  of  late  developmental  inactivation  that  appear  to
orrelate  with  the  entry  of  brain  regions  into  terminal  dif-
erentiation  pathways  that  are  induced  by  glucocorticoids
Brown  et  al.,  1996a;  Holmes  et  al.,  2006b).  Moreover,  at
east  in  rodents,  though  fetal  programming  by  maternal  mal-
utrition  is  associated  with  elevated  fetal  glucocorticoid
evels,  these  appear  of  fetal  adrenal  rather  than  maternal
irculation  origins  (Cottrell  et  al.,  2012).  This  might  suggest
 role  for  fetal  tissue  catabolism  of  glucocorticoids  in  modu-
ating  brain  development.  To  interrogate  this  we  generated
 brain-speciﬁc  knockout  of  11-HSD2,  effective  from  early
etal  life,  and  determined  the  effects  on  neurodevelopment,
ffective  and  cognitive  behaviors,  neurotransmitter  levels
nd  central  gene  expression.
. Materials and methods
.1.  Mice
rain-speciﬁc  knock  down  of  11-HSD2  (HSD2BKO)  mice
ere  generated  by  crossing  11-HSD2ﬂx/ﬂx mice  (Artemis
harmaceuticals,  Cologne,  Germany)  with  a  Cre  mouse  line
riven  by  the  Nestin  promotor  (Tronche  et  al.,  1999),  which
s  expressed  in  proliferating  CNS  cells.  For  more  infor-
ation  on  the  breeding  schedule,  housing  conditions  and
eriﬁcation  of  control  mice  see  Supplementary  Information
SI)  Methods.  Studies  were  carried  out  in  strict  accordance
ith  the  UK  Home  Ofﬁce  Animals  (Scientiﬁc  Procedures)
ct,  1986  and  the  European  Communities  Council  Direc-
ive  of  24  November  1986  (86/609/EEC)  and  were  assessed
y  the  University  of  Edinburgh  Ethical  Review  Committee.
ll  experiments  were  performed  blind  to  genotype  on  male
ice  using  littermate  controls  (CON).  Female  offspring  were
ot  assessed  in  this  study  due  to  the  potential  confounding
ffects  of  the  oestrous  cycle.
.2.  Tissue  collections
renatal  tissue  collections  were  taken  at  E12.5,  E15.5  or
17.5  to  assess  11-HSD2  activity  (Brown  et  al.,  1993),
orticosterone  levels,  and/or  gene  expression  in  CON  and
SD2BKO  fetal  and  placental  tissues  (see  SI  Methods).
t  postnatal  day  (P)  21,  cerebellum  were  dissected  and
ssessed  for  morphological  changes  as  described  by  Holmes
t  al.  (2006b).  Adult  brains  and  adrenals  were  collected  and
rocessed  as  described  in  SI  Methods.
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RFetal  brain  11-HSD2  and  programmed  behavior  
2.3.  Neurodevelopment  markers
To  determine  the  rate  of  development  of  postnatal  func-
tional  neural  maturation,  negative  geotaxis  and  timing  of
eye  opening  were  assessed  at  P7  and  P14  respectively
(Holmes  et  al.,  2006b).  For  negative  geotaxis,  pups  were
removed  from  their  mothers  and  placed  on  an  inclined  plane
of  approximately  30◦ with  their  head  facing  downwards.  The
number  of  mice  which  completed  a  reﬂex  turn  to  face  up  the
slope  within  a  1  min  period  was  recorded.
2.4.  Behavioral  testing
All  behavioral  tests  were  performed  during  the  light  period
between  08:00  and  13:00  h  on  male  mice  between  3  and  4
months  of  age.  When  appropriate,  all  behavioral  tests  were
recorded  using  the  LimelightTM video  tracking  system  (Acti-
metrics  Inc.,  IL,  USA)  to  enable  analysis.
Elevated  plus  maze: Exploratory  behavior  of  the  ele-
vated  plus  maze  was  assessed  for  5  min  (Holmes  et  al.,
2006a)  with  decreased  exploration  of  the  open  arms/total
movement  indicative  of  anxiety-like  behavior.  Open  ﬁeld:
Exploration  of  the  open  ﬁeld  was  assessed  as  previously
described  (Holmes  et  al.,  2006a),  and  mice  were  allowed
to  explore  for  5  min.  Decreased  exploration  of  the  center
was  indicative  of  anxiety-like  behavior.  Tail  suspension:  The
tail  suspension  test  was  adapted  from  (Steru  et  al.,  1985).
Mice  were  individually  suspended  from  a  shelf  above  a  table
using  an  adhesive  tape  placed  0.5  cm  from  the  tip  of  the
tail.  Mice  were  scored  every  5  s  for  6  min  as  either  struggling
or  immobile,  with  immobility  an  indicator  of  depressive-
like  characteristics.  Forced  swim  test:  Mice  were  placed  for
6  min  in  a  5  L  glass  beaker  ﬁlled  to  a  depth  of  15  cm  (3  L)
with  tepid  (22—25 ◦C)  tap  water.  At  5  s  intervals,  mice  were
scored  as  either  swimming/struggling  or  climbing  versus
ﬂoating,  with  ﬂoating  an  indicator  of  depressive-like  behav-
ior.  Novelty-induced  hypophagia  (NIH):  To  conduct  the  NIH
study  methods  were  adapted  from  Mombereau  et  al.  (2010).
Brieﬂy,  singly  housed  mice  were  initially  trained  to  consume
chocolate  chips  from  a  plastic  petri  dish  in  their  home  cage
for  5  days  and  on  the  6th  day,  the  test  paradigm  was  carried
out  in  a  novel  environment  for  5  min  and  distance  travelled
and  latency  to  eat  were  recorded,  with  a  longer  latency  to
eat  an  indicator  of  depressive-like  behavior.  Morris  water
maze  test:  The  Morris  water  maze  was  used  to  assess  behav-
ior  associated  with  learning  and  memory  of  the  CON  and
HSD2BKO  mice.  Procedures  were  followed  as  detailed  by
Yau  et  al.  (2001).  Latency  to  escape  the  water  is  a  mea-
sure  of  learning  ability.  At  the  end  of  day  ﬁve,  mice  were
given  a  probe  trial  whereby  the  platform  was  removed  and
the  time  and  direction  of  swim  search  was  considered  to  be
an  indicator  of  memory  retention.  Object  Recognition: The
procedure  for  these  tasks  was  informed  by  previous  publica-
tions  (Cost  et  al.,  2014).  Mice  were  acclimatised  over  5  days
to  the  behavioral  arena  and  two  objects.  Object  recognition
consisted  of  a  sample  and  a  test  phase,  whereby  in  the  sam-
ple  phase,  each  animal  was  allowed  to  explore  2  identical
novel  objects  for  5  min,  followed  by  a  1  h  interval  before  the
test  phase.  Here  one  object  was  replaced  by  a  completely
novel  object.  The  mouse  was  then  allowed  to  explore  the
objects/box  for  5  min  and  the  time  spent  actively  exploring
m
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ach  object  was  recorded.  Object  in  Place:  Each  mouse  was
cclimatised  to  the  test  box  containing  4  objects  over  a  5
ay  period.  The  sample  phase  of  the  experiment  involved
he  mouse  being  placed  in  the  box  equipped  with  four  dif-
erent  novel  objects  for  7  min.  Time  spent  exploring  each
f  the  4  objects  was  recorded.  Following  a delay  of  5  m  or
 h  the  mice  were  returned  to  the  box  for  the  test  phase  of
 min,  where  2 of  the  objects  had  exchanged  positions.  The
mount  of  time  spent  exploring  each  object  was  recorded.
he  Discrimination  ratio  was  calculated  as  an  index  of  mem-
ry  performance  (time  at  novel  −  time  at  familiar)/(time  at
ovel  +  time  at  familiar).  For  each  mouse,  the  mean  discrim-
nation  ratio  for  each  task  was  obtained  by  calculating  the
ean  of  the  discrimination  ratios  for  the  2  trials  on  that
ask.
.5.  Rotarod
o  assess  general  agility  and  balance  of  the  mice,  they
ere  individually  placed  onto  a  rotating  rod,  which  gradually
ncreases  in  rotation  velocity.  The  length  of  time  the  mice
tayed  on  the  rod  once  rotation  commenced  was  recorded.
.6.  Food  and  water  intake
ON  and  HSD2BKO  mice  were  individually  housed  in  food
nd  drink  monitoring  cages  (TSE  Systems,  Bad  Homburg,
ermany)  and  their  food  and  drink  intake  measured  every
inute  using  Drink  (TSE  Systems,  Bad  Homburg,  Germany).
ice  were  allowed  to  acclimatise  for  three  days  and  average
ourly  intakes  were  calculated  for  four  24  h  cycles.
.7.  Assessment  of  HPA  axis  function
lood  samples  were  collected  from  singly  housed  adult  ani-
als  by  tail  nick  at  0700  h  and  2000  h  in  order  to  assess
adir  and  peak  circulating  corticosterone  levels.  In  a  sep-
rate  cohort  of  animals,  HPA  axis  response  to  acute  stress
as  assessed  by  placing  animals  into  a restraint  tube  for
0  min.  Blood  samples  were  collected  by  tail  nick  before
nimals  were  placed  into  a  restraint  tube  (T0),  30  min  into
he  restraint  tube  (T30)  and  one  hour  post-restraint  stress
T90).  Blood  was  collected  into  EDTA-coated  Microvette
ubes  (Sarstedt,  Numbrecht,  Germany)  and  centrifuged,  and
lasma  stored  at  −20 ◦C  until  corticosterone  determination
y  radioimmunoassay  as  described  previously  (Holmes  et  al.,
997).
.8.  CNS  expression  analyses
n  situ  hybridisation  was  performed  as  described  previ-
usly  (Harris  et  al.,  2001).  Mouse  brain  sections  were
ssessed  for  serotonin  receptor  1A  (Htr1a;  hippocampus,
ortex,  baserolateral  amygdala,  dorsal  and  medial  Raphe
uclei),  tryptophan  hydroxylase  2  (Tph2;  dorsal  and  medial
aphe  nuclei),  serotonin  transporter  (Slc6a4;  dorsal  and
edial  Raphe  nuclei), dopamine  receptor  D2  (Drd2;  caudate
utamen,  nucleus  accumbens  core  and  shell), dopamine
ransporter  (Slc6a3;  ventral  tegmental  area,  substantia
igra), mineralocorticoid  receptor  (Nr3c2;  hippocampus),
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lucocorticoid  receptor  (Nr3c1;  paraventricular  nucleus
PVN),  hippocampus) and  corticotrophin-releasing  hormone
Crh;  PVN). Expression  of  Hsd11b1  and  Hsd11b2  in  fetal
rain,  and  Nr3c1  and  Nr3c2  in  adult  hippocampi  were
ssessed  by  quantitative  real-time  RT-PCR  (Wyrwoll  et  al.,
009).  For  more  detail  see  SI  Methods.
.9.  High  performance  liquid  chromatography
HPLC)
rains  were  dissected  into  cortex,  diencephalon,  hippocam-
us  and  hindbrain.  The  dissected  samples  were  weighed  and
omogenised  in  200  l 0.1  M  perchloric  acid  (PCA),  sonicated
wice  for  10  s and  spun  (10,000  ×  g,  5  min,  4 ◦C).  The  super-
atant  was  processed  for  HPLC  measurement  of  monoamines
nd  their  metabolites  as  described  in  SI  Methods.
.10.  Cardiovascular  parameters
ean  arterial  blood  pressure,  urinary  sodium  excretion,
odium  potassium  ratio  and  haematocrit  were  measured  in
naesthetised  CON  and  HSDBKO  mice  according  to  Hunter
t  al.  (2014).
.11.  Statistical  analysis
ll  data  are  expressed  as  group  means  ±  SEM.  Statistical
nalyses  were  conducted  with  Graphpad  Prism  v5  or  6.0d,
sing  either  unpaired  t-test,  one-  or  two-way  ANOVA  and
here  appropriate,  this  was  followed  by  a  post  hoc  Tukey’s
SD  test.  Corticosterone  levels  obtained  from  the  restraint
tress  studies  were  analysed  using  two-way  ANOVA  with
epeated  measures.  Values  are  considered  statistically  sig-
iﬁcant  at  p  <  0.05.
. Results
.1.  Veriﬁcation  of  11-HSD2  removal  from  the
eveloping brain
rain-speciﬁc  knock  down  of  11-HSD2  substantially  reduced
75%)  11-HSD2  activity  (Fig.  1A)  and  (96%)  Hsd11b2  mRNA
Fig.  1B)  in  the  fetal  head  at  E12.5  (the  peak  of  ges-
ational  11-HSD2  expression)  in  comparison  to  wild-type
ontrol  (CON)  littermate  fetuses.  By  E17.5,  near  the  end
f  gestation,  11-HSD2  activity  was  dramatically  decreased
n  both  genotypes  (CON:  0.5222  ±  0.0943  nmol/mg/h,
 =  6;  HSD2BKO:  0.2466  ±  0.0699  nmol/mg/h,  n  =  5)  how-
ver  a  decreased  activity  was  still  observed  in  the
SD2BKO  brains  (p  =  0.05).  Hsd11b2  mRNA  levels  were
lso  extremely  low  at  E17.5  with  no  difference  between
enotype  at  this  stage  (Fig.  1B).  However,  HSD2BKO
ad  no  effect  on  11-HSD2  activity  in  fetal  body  or
lacenta  (Fig.  1A).  11-HSD2  activity  was  not  altered
n  HSD2BKO  adult  kidneys  (CON  64.36  ±  10.61  nmol  11-
ehydrocorticosterone  (11DHC)/mg/h,  n  =  7  vs.  HSD2BKO
4.28  ±  7.15  nmol  11DHC/mg/h,  n  =  6),  the  main  site  of
dult  expression,  where  11-HSD2  determines  aldosterone-
elective  effects  on  renal  salt-water  physiology.
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In  the  adult  mouse  brain,  11-HSD2  expression  is
imited  to  the  nucleus  of  the  tractus  solitarius  (NTS;
olmes  et  al.,  2006b),  where  the  enzyme  might  inﬂu-
nce  blood  pressure  and  electrolyte/ﬂuid  volume  balance.
owever,  no  differences  were  observed  between  CON  and
SD2BKO  littermates  in  mean  arterial  blood  pressure  (CON:
1.2  ±  3.4  mmHg,  n  =  7;  HSD2BKO:  74.1  ±  4.5  mmHg,  n  =  7),
rinary  sodium  excretion  (CON:  0.231  ±  0.067  mol/min,
 =  7;  HSD2BKO:  0.319  ±  0.067  mol/min,  n  =  7),  urinary
odium:potassium  ratio  (CON:1.831  ±  0.383,  n  =  6;  HSD2BKO
.627  ±  0.7037,  n  =  7)  or  haematocrit  (CON:  42.7  ±  0.6%;
SD2BKO:  41.2  ±  1.7%,  n =  7).  These  data  indicate  that  adult
idney  function,  blood  pressure  and  volume  homeostasis  are
ot  affected  by  deletion  of  11-HSD2  within  the  fetal  or
dult  brain.  Loss  of  HSD2  in  the  adult  brain  (NTS)  is  not  antic-
pated  to  affect  affective  or  cognitive  behavior,  however
t  is  conceivable  (but  unlikely)  that  extremely  low  levels
f  11-HSD2  transcripts  elsewhere  in  the  brain  may  have  a
iological  function.  HSD2BKO  mice  therefore  enable  deter-
ination  of  whether  11-HSD2  expression  in  the  fetal  brain
odulates  glucocorticoid  programming  of  behavior  in  later
ife,  despite  normal  placental  and  kidney  expression.
.2.  Effects  of  deleting  brain  11-HSD2  on  basic
henotype parameters
eleting  11-HSD2  from  the  brain  had  no  impact  on
endelian  ratio,  placental  or  fetal  weights  at  E15.5  and
17.5,  nor  birthweight  or  pup  survival,  when  compared  to
ittermate  controls  (data  not  shown).  These  data  are  indica-
ive  of  normal  growth  of  the  placenta  and  fetus,  which
s  in  contrast  to  the  growth  retardation  observed  in  the
lobal  11-HSD2  knockout  model  —  similarly  compared  to
ittermates  (Holmes  et  al.,  2006a;  Wyrwoll  et  al.,  2009).
ody  weight  was  unaltered  between  CON  and  HSD2BKO  off-
pring  until  after  weaning  when  a  reduction  in  body  weight
f  ∼10%  was  observed  in  the  HSD2BKO  offspring  (Figure
1).  Further  investigations  revealed  that  this  growth  trajec-
ory  closely  followed  that  of  NestinCre  animals  (Figure  S1),
herefore  the  differences  in  body  weight  are  attributable  to
he  presence  of  Cre  in  the  HSD2BKO  offspring  as  opposed  to
entral  removal  of  11-HSD2.  Neurodevelopment  markers
nd  cerebellar  morphology  were  unaltered  in  HSD2BKO  in
omparison  to  controls  (Table  S2);  which  is  also  in  contrast
o  11-HSD2−/− mice  (Holmes  et  al.,  2006b).  Locomotor
ctivity  and  balance  (rotarod  performance)  were  similar
cross  littermate  genotypes  (latency  to  fall  in  CON  mice:
10.23  ±  34.5  s vs.  HSD2BKO:  105.17  ±  19.84  s),  indicating
o  motor  impairment  that  could  confound  behavioral  tests.
here  were  no  differences  in  food  or  water  intake  between
ON  and  HSD2BKO  mice.
.3.  HSD2BKO  mice  exhibit  transiently  increased
etal brain  corticosterone  levels
o  determine  whether  the  reduction  in  11-HSD2  activity
n  the  fetal  brain  has  a  functional  consequence,  we  mea-
ured  brain  corticosterone  levels,  which  we  hypothesised
ould  be  increased  due  to  loss  of  a  local  glucocorticoid-
nactivating  pathway  in  the  HSD2BKO  mice.  Corticosterone
n  fetal  brain  was  increased  at  E15.5  in  HSD2BKO  compared
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Figure  1  (A)  Feto-placental  11-HSD2  activity  at  E12.5.  11-HSD2  activity  is  reduced  in  the  fetal  head  of  E12.5  HSD2BKO  mice
(n =  6)  in  comparison  to  controls  (n  =  6).  Within  the  placenta  and  the  remainder  of  the  fetal  body  11-HSD2  activity  was  unaltered
by phenotype  (n  =  5—7).  **p  <  0.005  compared  to  controls.  (B)  Hsd11b2  mRNA  levels  in  fetal  brain.  Hsd11b2  mRNA  levels  are  reduced
dramatically at  E12.5  in  HSD2BKO  (n  =  5)  compared  to  controls  (n  =  5)  while  minimal  expression  is  seen  in  either  genotype  at  E17.5
(n =  4—5).  2-Way  ANOVA  reveals  signiﬁcant  effects  of  genotype  (F(1,15)  =  9.697,  p  =  0.007),  age  (F(1,15)  =  9.519,  p  =  0.0075)  and
interaction (F(1,15)  =  9.498,  p  =  0.0076).  (C)  Brain  corticosterone  content  at  E15.5  and  E17.5.  Corticosterone  content  is  increased
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gin brain  of  E15.5  HSD2BKO  (n  =  10)  compared  to  controls  (n  =  9).
to  CON,  at  a  time  when  fetal  brain  11-HSD2  expression
is  normally  high  (2-way  ANOVA  shows  a  signiﬁcant  inter-
action  of  genotype  and  age,  F(1,27)  =  45.59,  p  <  0.05;  post
hoc  t-test  comparing  genotypes  at  E15.5  p  <  0.05;  Fig.  1B).
Importantly,  no  difference  in  brain  corticosterone  concen-
trations  was  observed  at  E17.5  (Fig.  1B),  an  age  when  most
of  brain  11-HSD2  expression  has  been  repressed  (Brown
et  al.,  1996a;  Diaz  et  al.,  1998).  There  was  no  effect  of  dele-
tion  of  11-HSD2  on  brain  expression  of  11-HSD1  activity
(E17.5;  conversion  of  11-dehydrocorticosterone  to  cortico-
sterone;  CON:  0.113  ±  0.035  nmol/mg/h,  n  =  5;  VS  HSD2BKO:
0.110  ±  0.045  nmol/mg/h,  n  =  6)
3.4.  HSD2BKO  mice  exhibit  no  changes  in  HPA  axis
function
Glucocorticoid  programming  in  several  models,  such  as  pre-
and  post-natal  stress,  results  in  hyperactivity  of  the  HPA
a
p
H0.05  compared  to  Controls.
xis  in  development  and  throughout  life  (Harris  and  Seckl,
011).  This  phenomenon  was  not  observed  in  global  11-
SD2−/− adult  mice,  except  for  decreased  adrenal  weights,
ost  likely  resulting  from  a  prolonged  half-life  of  cortico-
terone  due  to  decreased  catabolism  largely  in  the  kidneys,
eading  to  the  need  for  less  HPA  axis  drive  to  maintain  normal
lasma  glucocorticoid  levels.  Compatible  with  this  notion,
rain-speciﬁc  deletion  of  11-HSD2  had  no  effect  on  adrenal
eight  (Table  1).
Expression  of  genes  involved  in  regulation  of  the  HPA
xis  and  glucocorticoid  signaling  (corticotrophin  releasing
ormone  (Crh), Nr3c1  and  Nr3c2) in  the  hypothalamus  and
ippocampus  were  unchanged  in  HSD2BKO  compared  to  CON
Table  1).  Plasma  corticosterone  levels  were  similar  between
enotypes  at  E17.5  and  in  the  adult  offspring  both  basally
nd  in  response  to  restraint  stress  (Table  1).  Thus,  HPA  axis
arameters  were  not  altered  in  the  fetus  or  adult  by  11-
SD2  deletion  in  the  brain.
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Table  1  The  effect  of  HSD2BKO  on  HPA  axis  parameters.
CON  HSD2BKO
Adrenal  size:  body  weight  (adult)  5.9  ±  0.9  ×  10−4 (15)  4.9  ±  0.9  ×  10−4 (18)
Brain gene  expression  (n  =  5—8)
Crh (E15.5;  PVN)(ROD)  0.336  ±  0.01  0.320  ±  0.026
Crh (E17.5;  PVN)(ROD)  0.274  ±  0.0181  0.252  ±  0.016
Nr3c2 (E15.5;  HC)(ROD)  ND  ND
Nr3c2 (E17.5;  HC)(ROD)  0.26  ±  0.02  0.26  ±  0.01
Nr3c2 (Adult;  HC)  (norm  to  HPRT)  0.868  ±  0.077  0.818  ±  0.061
Nr3c1 (Adult;  HC)(norm  to  HPRT) 0.733  ±  0.170 0.744  ±  0.055
Hsd11b1 (E12.5;  norm  to  HPRT) 0.172  ±  0.033 0.155  ±  0.021
Hsd11b1 (E17.5;  norm  to  HPRT) 0.188  ±  0.028 0.148  ±  0.022
Plasma corticosterone  (nmol/l)
Fetal  (E17.5)  31.2  ±  2.1  28.1  ±  2.0
Adult (10)  (9)
AM 35.3  ±  4.8  34.3  ±  6.7
PM 196.5  ±  16.6  179.9  ±  22.9
Restraint stress  corticosterone  levels  (nmol/l)  (12)  (12)
0 min  restraint  stress  33.8  ±  4.7  35.9  ±  5.3
30 min  restraint  stress  622.9  ±  87.4  661.0  ±  98.1
1 h  post  restraint  stress  155.7  ±  27.8  181.9  ±  26.8
There were no signiﬁcant differences between CON and HSD2BKO in any of the parameters of the HPA axis. Values are mean ± SEM,
(N). PVN, nucleus; HC, hippocampus; ROD, relative optical density; ND, not detectable; norm HPRT, genes expression normalised to
housekeeping gene, hypoxanthine phosphoribosyltransferase. Fetal Nr3c1 could not be quantitated due to very high neuroepthelia
3
H
3
b
A
e
t
g
o
d
n
t
t
(
t
g
t
C
z
1
C
n
d
t
o
T
w
p
3
W
s
s
s
t
m
H
t
a
w
t
s
b
f
T
t
3
A
p
w
n
t
a
bexpression masking hippocampal expression.
.5.  Programmed  behavioral  phenotype  in
SD2BKO
.5.1.  HSD2BKO  mice  do  not  exhibit  anxiety-like
ehaviors
s  the  offspring  of  maternal  stress  or  11-HSD2−/− mice
xhibit  increased  anxiety,  we  determined  if  11-HSD2  in
he  brain,  rather  than  the  placenta,  protects  against  pro-
ramming  of  affect.  Exploration  (%distance  travelled  on  the
pen  arms/total  distance)  of  the  elevated  plus  maze  (EPM)
id  not  differ  between  CON  and  HSD2BKO  littermates  under
ormal  conditions  (Fig.  2A).  Similarly,  no  effect  of  geno-
ype  was  observed  on  total  distance  travelled  throughout
he  maze  or  the  time  spent  in  the  anxiogenic  open  arms
data  not  shown).  Restraint  stress  decreased  exploration  of
he  open  arm  of  EPM  (Fig.  2A)  but  this  was  also  unaltered  by
enotype.
Total  movement  within  the  open  ﬁeld  and  exploration  of
he  more  anxiogenic  inner  zones,  did  not  differ  between
ON  and  HSD2BKO  animals  (distance  travelled  in  inner
one  by  CON  mice:  13.14  ±  8.31  cm;  n  =  12  vs.  HSD2BKO:
3.02  ±  7.60  cm;  n  =  11.  Time  spent  in  the  inner  zone  by
ON  mice:  2.32  ±  0.47  s,  n  =  12  vs.  HSD2BKO:  1.93  ±  0.56  s,
 =  11).  Hence  removing  11-HSD2  from  the  brain  during
evelopment  did  not  impact  on  anxiety  behavior.  In  simul-
aneous  experiments,  the  increased  anxiety-like  phenotype
−/−f  the  global  11-HSD2 was  conﬁrmed  (data  not  shown).
hese  data  suggest  that  11-HSD2  in  the  placenta  (or  else-
here  in  the  fetus),  rather  than  the  brain,  determines
rogramming  of  anxiety-like  behaviors.
i
5
H
t.5.2.  HSD2BKO  mice  exhibit  ‘depressive-like’  behavior
e  carried  out  three  tests  of  depressive-like  behavior:  tail
uspension,  novelty-induced  hypophagia  (NIH)  and  forced-
wim  tests.  In  the  tail  suspension  test,  HSD2BKO  animals
pent  a  greater  proportion  of  time  hanging,  as  opposed
o  struggling,  than  CON  littermates  (Fig.  2B),  indicating  a
ore  depressive-like  behavioral  phenotype.  In  the  NIH  test,
SD2BKO  mice  exhibited  an  increased  latency  to  feed  on
he  test  day  in  comparison  to  CON  littermates  (Fig.  2C)
lso  indicative  of  increased  depressive-like  behavior.  There
ere  no  differences  in  the  training  response  or  the  distance
ravelled  in  the  novel  cage  between  genotypes.  The  forced
wim  test  revealed  no  signiﬁcant  differences  in  behavior
etween  the  genotypes  (Fig.  2D)  though  there  was  a  trend
or  HSD2BKO  to  ﬂoat  more  (a  depressive-like  behavior).
hus,  HSD2BKO  mice  exhibit  more  depressive-like  behaviors
han  littermate  controls.
.5.3.  Memory  is  impaired  in  HSD2BKO  mice
dverse  early-life  environments  are  also  associated  with
rogramming  of  cognitive  impairments.  Hence  we  explored
hether  deletion  of  11-HSD2  within  the  brain  alters  cog-
ition  in  object  recognition  (OR)  and  object-in-place  (OiP)
asks,  described  in  Fig.  3A.  HSD2BKO  mice  did  not  display
ny  deﬁcits  compared  to  CON  in  the  OR  task  (Fig.  3B(i))
ut  overt  cognitive  defects  emerged  when  mice  were  tested
n  the  more  complex,  demanding  OiP  test.  With  both  a
 min  or  a  1  h  delay  between  sample  and  test  phase,  the
SD2BKO  mice  failed  to  discriminate  between  the  2  objects
hat  had  swapped  positions  and  the  two  that  had  remained  in
Fetal  brain  11-HSD2  and  programmed  behavior  65
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Figure  2  Anxiety-like  and  depressive-like  behaviors  in  HSD2BKO  mice  compared  to  littermate  controls  (CON).  (A)  Exploration
of the  open  arms  of  the  Elevated-plus  maze  (EPM)  did  not  differ  between  genotypes  although  restraint  stress  prior  to  testing  did
reduce exploration  of  the  open  arm  (*p  <  0.05,  Two-way  ANOVA  F(1,63)  =  6.07,  n  =  10—23).  HSD2BKO  exhibited  increased  depressive-
like behavior  in  the  B.  Tail  suspension  test  (TST;  t-test  t  =  2.25)  and  (C)  Novelty  Induced  hypophagia  test  (NIH;  t-test  t  =  2.14),  with
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ma trend  for  the  HSD2BKO  mice  to  spend  more  time  ﬂoating  in  t
and 9  (HSD2BKO).  *p  <  0.05  compared  to  CON.
the  same  positions  as  in  the  sample  phase  (the  discrimina-
tion  ratio  was  not  different  from  0;  p  =  0.084  and  p  =  0.51
for  5  min  and  1  h  respectively),  while  control  littermates
showed  discrimination  at  both  time  delays  by  investigat-
ing  the  moved  objects  longer  than  the  objects  that  were
in  their  original  position.  Furthermore,  there  was  a  signiﬁ-
cant  reduction  in  memory  in  the  HSD2BKO  compared  to  CON
mice  in  this  test  at  both  5  min  and  1  h  delay  (DR  for  5  min
delay  was  signiﬁcantly  different  between  genotypes,  t-test
t  =  8.427,  df  =  14,  p  =  0.001;  DR  for  1  h  delay,  t-test  t  =  4.484,
df  =  14,  p  =  0.001.  p  <  0.0001;  Fig.  3B(ii  and  iii)).
In  a  spatial  reference  memory  task  conducted  in  the  Mor-
ris  water  maze,  HSD2BKO  mice  did  not  differ  from  CON  mice
in  the  swim  speed  (CON:  23.5  ±  1.5  cm/s,  n  =  10;  HSD2BKO
25.2  ±  0.9  cm/s,  n  =  10),  visible  platform  trial  (latency  to
platform:  CON:  21.6  ±  5.2  s,  n  =  10;  HSD2BKO  21.7  ±  5.0  s,
n  =  10)  or  probe  trial  (latency  to  platform:  CON:  17.5  ±  6.9  s,
n  =  10;  HSD2BKO  14.7  ±  3.8  s,  n  =  10).  They  did  however
exhibit  small  differences  in  spatial  learning  at  speciﬁc  times
during  the  training  phase,  with  HSD2BKO  mice  demonstrat-
ing  a  delay  in  locating  the  platform  on  Day  3  (Fig.  4A).  Similar
t
H
ﬁ
dorced  swim  test  (FST;  D).  Values  are  mean  ±  SEM,  n  =  11  (CON)
elays  in  task  learning  were  also  seen  in  global  11-HSD2−/−
ice  between  Day  1  and  2  (Fig.  4B).  Hence,  only  minor  deﬁ-
iencies  in  learning  this  task  was  observed  in  mice  lacking
1-HSD2  in  the  brain  or  globally  and  therefore  only  very
omplex  demanding  tasks  are  able  to  reveal  the  cognitive
eﬁcit,  at  least  in  young  mice.
.6.  Neurotransmitter  levels  are  unaltered  but
-HT1A receptor  mRNA  expression  is  decreased  in
he hippocampus  of  HSD2BKO  mice
evels  of  neurotransmitters  and  their  receptor  mRNAs  which
nderpin  affective  behaviors  were  measured  in  selected
rain  areas.  No  differences  were  observed  in  serotonin,
opamine  or  their  metabolites  between  CON  and  HSD2BKO
ice  in  any  brain  region  investigated  (Table  S3),  contraryo  observations  in  global  11-HSD2−/− mice.  Strikingly,  5-
T1A receptor  (Htr1a) mRNA  levels  were  reduced  in  the  CA1
eld  of  the  hippocampus  in  HSD2BKO  mice  (t-test  t  =  2.329,
f  =  9,  p  =  0.0457;  Fig.  4C).  Representative  autoradiographs
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Figure  3  Cognitive  behaviors  in  HSD2BKO  compared  to  CON  mice.  (A)  A  cartoon  describes  the  object  recognition  (OR)  test  where
sample phase  enables  the  mouse  to  investigate  two  objects  followed  by  a  test  phase  where  one  object  is  changed  to  a  new  one,
the time  the  mouse  investigates  both  the  known  and  novel  objects  is  measured  and  the  discrimination  ratio  is  then  calculated.  The
higher the  ratio  the  more  the  mouse  has  recognised  the  object  is  novel.  The  second  cartoon  describes  the  Object-in-Place  (OiP)
task. This  test  involves  4  objects  in  the  sample  phase  and  in  the  test  phase  two  of  the  objects  have  switched  place.  (B)  (i)  Object
recognition task  in  C0N  and  HSD2BKO  revealed  in  performance  in  this  task  between  genotypes.  However  in  the  more  demanding  task
of OiP,  while  the  CON  mice  can  discriminate  when  objects  have  been  moved  to  a  different  place,  the  HSD2BKO  mice  are  unable  to  do
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 =  8—9.  ***p  <  0.001  compared  to  CON.
f  Htr1a  expression  in  both  genotypes  are  shown  in  Figure
2.  A  similar  down-regulation  of  Htr1a  mRNA  was  observed
n  the  same  subﬁeld  of  the  hippocampus  of  global  11-
SD2−/− compared  to  HSD2+/+ littermates  (1-way  ANOVA
(2,15)  = 5.234,  p  =  0.0189;  Tukey’s  post  hoc  test  p  =  0.050;
ig.  4D).  No  changes  between  genotypes  were  observed  in
RNA  levels  of  Tph2, Slc6a4, Drd2, or  Slc6a3  in  any  brain
egion.
. Discussion
e  show  that  absence  of  11-HSD2  solely  in  the  develop-
ng  brain  results  in  a  speciﬁc,  delineated  stratiﬁcation  of
he  phenotype  observed  in  complete  feto-placental  11-
SD2  deﬁciency.  Thus,  increased  depressive-like  behaviors
nd  cognitive  impairments  in  adulthood  are  related  to  loss
f  11-HSD2  in  the  fetal  CNS,  whilst  the  anxiety  component
f  global  11-HSD2  deﬁciency  and  many  other  programming
odels,  is  not  observed.  This  allows  dissection  of  poten-
ial  differential  mechanisms  underpinning  programming  of
mportant  brain  functions.
p
i
f
t (iii)  between  sample  and  test  phases.  Values  are  mean  ±  SEM,
The  fetal  growth  restriction  resulting  from  reduced
eto-placental  11-HSD2  expression  and  hence  placen-
al  dysfunction,  observed  in  most  models  of  prenatal
tress/glucocorticoid  overexposure  (including  global  11-
SD2−/− mice;  (Hewitt  et  al.,  2006;  Lucassen  et  al.,  2009;
yrwoll  et  al.,  2009) and  with  maternal  nutritional  restric-
ion  (Langley-Evans  et  al.,  1996)),  is  absent  in  HSD2BKO.
his  suggests  that  programming  of  the  fetus  in  this  model
s  caused  by  exposure  to  fetal  rather  than  maternal  corti-
osterone  and  is  a  direct  action  on  the  brain.  This  suggests
hat  HSD2BKO  contributes  to  programming  of  depressive-like
ehavior  but  not  growth  restriction,  whereas  feto-placental
1-HSD2  expression  contributes  to  both.  In  keeping  with
his,  fetal  brain  levels  of  corticosterone  are  elevated  in
SD2BKO  mice,  but  only  at  time-points  when  11-HSD2
xpression  is  high.  The  fetal  HPA  axis  is  not  overtly  altered
y  removal  of  11-HSD2  in  the  fetal  CNS  (unaltered  Crh
r3c1,  Nr3c2  mRNA  levels  in  the  fetal  PVN  and  hippocam-
us,  normal  plasma  corticosterone  in  the  fetus).  These  data
ndicate  that  glucocorticoids  accumulate  selectively  in  the
etal  brain  with  loss  of  local  11-HSD2.  Factors  that  disrupt
he  complex  patterns  (temporal  and  spatial)  of  11-HSD2
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Figure  4  Watermaze  learning  and  hippocampal  expression  of  5-HT1A receptor  mRNA  in  HSD2BKO  and  global  11-HSD2  KO  mice
(11-HSD2−/−).  (A)  During  the  watermaze  training  period  there  is  a  signiﬁcant  deﬁciency  in  performance  on  day  3  of  training  in
the HSD2BKO  compared  to  CON  (ˆp  <  0.05  compared  to  CON  day  3;  n  =  7—8).  (B)  11-HSD2+/+ and +/− mice  exhibit  a  signiﬁcant
improvement  in  performance  of  the  task  between  day  1  and  2,  whereas  11-HSD2−/−,  do  not  exhibit  an  improvement  (n  =  8—10).
Hippocampal  Htr1a  mRNA  expression  in  the  CA1  ﬁeld  of  HSD2BKO  (C)  and  heterozygous-bred  global  knockouts  of  11-HSD2  (D)  as
 decr
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gassessed by  in  situ  hybridisation  histochemistry  was  signiﬁcantly
*p <  0.05;  11-HSD2+/+,  11-HSD2+/− vs.  11-HSD2−/−:  n  =  6  in  al
inactivation  during  brain  development  would  therefore  be
of  substantial  interest.
Exposure  to  increased  glucocorticoids  during  fetal  devel-
opment  can  affect  working  and  reference  memory,  impair
long  term  potentiation  and  favour  long  term  depression
(Kamphuis  et  al.,  2003;  Yaka  et  al.,  2007).  The  occurrence  of
memory  deﬁcits  is  dependent  on  the  magnitude  and  duration
of  exposure  to  glucocorticoids  combined  with  the  stage  of
development  (Cannizzaro  et  al.,  2006;  Lemaire  et  al.,  2000;
Yaka  et  al.,  2007).  Here,  simple  hippocampus-encoded  ref-
erence  memory  tasks  were  minimally  affected  in  HSD2BKO
mice,  yet  marked  cognitive  defects  were  revealed  using
the  more  complex  object-in-place  task,  which  integrates
information  related  to  object  placement  and  object  recog-
nition  requiring  contributions  of  multiple  regions  including
the  hippocampus,  perirhinal  cortex  and  the  medial  pre-
frontal  cortex  (Barker  et  al.,  2007;  Barker  and  Warburton,
t
p
weased  in  comparison  to  controls  (CON:  n  =  5  vs.  HSD2BKO:  n  =  6;
s,  *p  <  0.05,  one-way  ANOVA).  Values  are  mean  ±  SEM;  n  =  5—6.
011).  Whether  the  cognitive  deﬁcits  observed  in  HSD2BKO
ice  is  driven  by  a  single  brain  locus  particularly  sen-
itive  to  developmental  glucocorticoid  actions  or  is  the
esult  of  the  increased  task  challenge  on  a  generally  dys-
unctional  CNS  remains  unclear.  Such  effects  ﬁt  with  the
ognitive  defects  observed  in  the  children  of  mothers  con-
uming  larger  amounts  of  licorice  in  pregnancy  (Raikkonen
t  al.,  2009).  All  of  the  behavioral  testing  was  done  in  the
arly  light  phase,  while  circadian  effects  on  behavior  are  at
resent  unknown.
Many  early-life  manipulations,  for  example  prenatal
tress,  are  associated  with  life-long  overactivity  of  the
PA  axis  hence  generating  the  hypothesis  that  elevated
lucocorticoid  levels  may  cause  the  observed  pheno-
ype  resulting  from  glucocorticoid  programming.  However
rogramming  of  affective  behaviors  was  not  associated
ith  major  modiﬁcations  of  HPA  axis  function  in  either
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1-HSD2−/− (Holmes  et  al.,  2006a)  or  HSD2BKO  mice.
lthough,  HPA  axis  changes  are  correlated  with  programming
nduced  by  prenatal  stress  across  many  species,  only  very
imited  data,  using  stress  timepoints  very  early  in  gestation,
as  reported  such  changes  in  the  mouse  to  date  (Mueller
nd  Bale,  2008).  It  is  unknown  if  the  mouse  is  relatively
esistant  to  HPA  axis  programming  or  whether  further  factors
eleased  in  response  to  stress  are  required  to  generate  these
ffects.  However,  HPA  axis  changes  per  se  are  not  likely  to
e  responsible  for  generation  of  the  affective  and  cognitive
henotypes,  at  least  with  11-HSD2  deﬁciency  and  perhaps
ther  challenges.
This  leaves  the  interesting  question  of  why  depres-
ive,  but  not  anxiety,  behaviors  are  programmed  in  the
SD2BKO.  The  incomplete  loss  of  11-HSD2  in  the  HSD2BKO
rain  may  be  involved.  However,  we  think  this  is  unlikely
s  although  the  HSD2BKO  has  ∼25%  11-HSD2  activity
n  the  brain  compared  to  controls,  the  mRNA  levels  are
egligible  (<4%).  Indeed,  in  a  prenatal  stress  model  the  anx-
ety  and  depressive-like  behaviors  appeared  to  be  due  to
wo  unrelated  psychopathologies  (Marrocco  et  al.,  2014).
his  behavioral  selectivity  may  therefore  be  generated  by
ndirect  signalling  of  factors  such  as  insulin-like  growth
actor  2  (which  facilitates  placental  response  to  fetal
rowth  demand  (Constancia  et  al.,  2005))  from  the  growth
estricted  placenta  and/or  fetus,  or  the  timing  (differ-
ntially  affecting  neural  circuitry)  and  magnitude  of  the
lucocorticoid  exposure  to  the  fetal  brain.  Whatever  the
asis,  separating  the  programming  of  depressive-like  and
nxiety-like  behaviors  is  of  substantial  interest.
Dysfunction  of  monoamine  signalling  occurs  in  affective
isorders  and  follows  glucocorticoid  exposure  in  early  life
Gartside  et  al.,  2003;  Goodfellow  et  al.,  2009;  Miyagawa
t  al.,  2011;  Muneoka  et  al.,  1997;  Van  den  Hove  et  al.,
006).  Htr1a  mRNA  expression  was  altered  in  both  global
nd  HSD2BKO  models,  with  a  consistent  downregulation  of
xpression  in  the  CA1  ﬁeld  of  the  hippocampus.  This  ﬁnd-
ng  is  of  key  interest,  as  altered  serotonin  responsiveness
f  CA1  hippocampal  neurons  as  a  consequence  of  stress
as  been  implicated  in  mood  disorders  (Krugers  et  al.,
010).  Indeed,  reduced  5HT1A receptor  binding  is  seen  in
he  brain  in  depression  in  humans  (Bhagwagar  et  al.,  2004;
argent  et  al.,  2000)  and  partial  5-HT1A receptor  agonists  are
ntidepressants  (Blier  and  Ward,  2003).  Decreased  binding
f  hippocampal  5-HT1A receptors  have  been  found  in  mod-
ls  of  early  life  stress  (Franklin  et  al.,  2011)  while  chronic
tress  alters  the  responsiveness  of  5-HT1A (Karten  et  al.,
999;  van  Riel  et  al.,  2003).  Environmental  enrichment
hich  reverses  programmed  affective  and  cognitive  behav-
ors  promotes  increased  expression  of  Htr1a  (Rasmuson
t  al.,  1998).  This  system  which  underpins  depressive-like
henotypes  appears  particularly  sensitive  to  glucocorticoid
rogramming  directly  in  the  fetal  brain.
There  has  been  considerable  research  into  the  regulation
f  11-HSD2  expression  in  placenta  (environmental  factors
uch  as  proinﬂammatory  cytokines,  glucocorticoids,  toxins,
nd  epigenetic  mark  changes  reported)  as  this  was  thought
o  be  the  main  site  of  expression  relevant  in  glucocorticoid
rogramming.  We  have  now  shown  that  the  brain  11-HSD2
s  important  too,  pressing  the  need  for  research  into  fetal
rain  regulation  of  11-HSD2.  Some  data  suggest  epigenetic
S
f
jC.  Wyrwoll  et  al.
hanges  occur  in  the  11-HSD2  promoter  in  fetal  hypothal-
mus  in  response  to  maternal  stress  (Jensen  Pena  et  al.,
012)  and  fetal  brain  11-HSD2  mRNA  responds  to  alter-
tions  in  maternal  nutrition  in  pigs  (Kanitz  et  al.,  2012).
owever,  more  studies  are  needed  to  determine  factors  that
egulate  11-HSD2  expression  in  the  brain  and  hence  the
usceptibility  to  psychiatric  diseases.
. Conclusions
n  sum,  we  show  that  fetal  brain  programming  of  speciﬁc
unctions  (depressive-like  behavior,  cognition)  is  powerfully
nﬂuenced  by  local  glucocorticoid  levels  determined  by  fetal
rain  11-HSD2,  whilst  programming  of  anxiety-like  behav-
or  and  the  HPA  axis  are  not  a direct  effect  of  local  11-HSD2
ontrol  of  glucocorticoid  access  to  the  brain.  These  data
llustrate  exquisite  and  complex  control  of  glucocorticoid
ction  upon  the  developing  CNS  and  imply  multiple  targets
n  the  control  of  the  trajectory  of  development  of  behavior,
ognition  and  neuroendocrine  function  during  normal  and
isordered  development.  Understanding  the  control  of  fetal
rain  11-HSD2  is  of  substantial  interest.
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